Original articleUnfavorable cytokine and adhesion molecule profiles during and after pregnancy, in women with gestational diabetes mellitusPerfiles de citocinas y moléculas de adhesión desfavorables durante y después del embarazo en mujeres con diabetes mellitus gestacional
Introduction
Gestational diabetes mellitus (GDM) is defined as carbohydrate intolerance that begins, or is first recognized, during pregnancy. It complicates about 1–14% of all pregnancies worldwide. GDM mothers and their offspring are at increased risk of developing type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). However, the mechanisms underlying these processes are unclear.1
Metabolic syndrome (MetS) is the clustering of central-trunk obesity, hypertriglyceridemia, low high-density lipoprotein (HDL) cholesterol, hypertension and dysglycemia. However, there is no consensus as to what defines MetS. Insulin resistance (IR) is proposed as the common link between the different manifestations of MetS and, as well, the cause of most of the associated abnormalities.2
Adipokines regulate glucose metabolism, insulin secretion and its activity, and fetal development. A high correlation between adiposity and IR with interleukin 6 (IL-6) concentrations has been described. High IL-6 secretion may aggravate IR in pregnancy and participate in the pathogenesis of GDM. Tumor necrosis factor alpha (TNF-α) has been used to predict GDM and its prognosis.3 TNF-α and IL-6 are involved in mechanisms that contribute to endothelial damage, including inhibition of endothelial nitric oxide synthase, vascular smooth muscle proliferation, and elevated concentrations of adhesion molecules.4 Pregnancy, such as obesity, associates a hypothalamic leptin resistance and, therefore, a rise in plasma leptin levels. However, the role of leptin in GDM is unclear.5 Adiponectin is a protein secreted exclusively by adipose tissue, with an inverse statistical correlation with MetS, together with a predictive role in the development of T2DM and atherosclerosis.6 Higher leptin, IL-6 and TNF-α with lower adiponectin levels in women with GDM compared with controls have been reported, together with low leptin, adiponectin, TNF-α and IL6 levels in offspring with macrosomia.6
Several cell adhesion molecules (AMs) are implicated in early stages of atherosclerosis development through the adhesion of monocytes to the endothelium cells. Among the AMs are: intercellular adhesion molecule-1 (ICAM-1), vascular adhesion molecule-1 (VCAM-1) and cellular molecule (E-selectin) all of which correlate with the concentrations of pro-inflammatory cytokines.7 Elevated E-selectin and VCAM-1 serum concentrations have been reported in women at risk of developing T2DM.8 This could be related to the degree of glycemic control that influences E-selectin concentrations through its effect on oxidative stress.9 Other markers of endothelial dysfunction include fibrinogen, microalbuminuria10 and hyperuricemia.11
Hence, the aim of the present study was to evaluate the levels of cytokines and AMs and CVD risk markers in women with GDM during and after pregnancy. The results could provide an insight into the pathogenesis of GDM as well as MetS.
Section snippets
Materials and methods
The study protocol was approved by the ethical committee of the University Hospital Puerta del Mar, and conformed to the guidelines of the Helsinki protocol.
Results
Demographic, clinical and laboratory variables of the studied population are summarized in Table 1. Treatment of GDM was diet in 68.9% and insulin in 31.1% of patients, with no significant differences in the variables analyzed.
In the postpartum period, diastolic BP and uric acid levels were significantly higher and glucose at 120′ post-75 g, C-peptide, lipid profile and albumin/creatinine ratio were significantly lower in patients with previous GDM. Conversely, controls showed significantly
Discussion
Our study showed a higher prevalence of MetS in women with previous GDM, significant differences in blood pressure, uric acid levels, albumin/creatinine ratio, as well as carbohydrate, lipid, adipokine, oxidative stress and endothelial function profiles; all of which are important factors for future development of CVD.
The relationship between GDM and MetS has been widely investigated, but with conflicting results. We had recently published data indicating that women with late-onset GDM had an
Conclusions
Our results suggest that inflammation, adipokines and AMs could be involved in the mechanisms underlying chronic insulin resistance and hyperglycemia in GDM. It is not yet known the possible importance of higher levels of TNF-α, leptin and AMs in the postpartum period respect to pregnancy. Therefore, an appropriate time-scale during pregnancy and postpartum should be determined for GDM women to take steps to decrease their risks. Data focusing on CVD in females with a history of GDM are still
Conflict of interest
The authors declare that they have no conflict of interest.
Acknowledgements
Editorial assistance was by Dr. Peter R Turner. This study was financed, in part, by grants from the Andalusia Department of Health (CTS-368: PI-0525-2012; PI-405/06; PI-11/00676).
References (30)
- et al.
Microalbuminuria as a target to improve cardiovascular and renal outcomes
Am J Kidney Dis
(2006) - et al.
Uric acid and oxidative stress: relative impact on cardiovascular risk?
Nutr Metab Cardiovasc Dis
(2007) - et al.
Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitus
Cytokine
(2012) - et al.
Relationship between circulating adipokines and insulin resistance during pregnancy and postpartum in women with gestational diabetes
Arch Med Res
(2011) - et al.
Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?
BMJ
(2002) The insulin resistance syndrome
Curr Atheroscler Rep
(2003)- et al.
Correlation between the inflammatory factors and adipocytokines with gestational diabetes mellitus and their change in puerperium
Zhonghua Fu Chan Ke Za Zhi
(2012) - et al.
Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year
Circulation
(2002) - et al.
Increased plasma leptin in gestational diabetes
Diabetologia
(2001) - et al.
Modulation of adipokines and cytokines in gestational diabetes and macrosomia
J Clin Endocrinol Metab
(2006)
Novel risk factors and markers for coronary disease
Adv Intern Med
Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1
Nature
E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: possible role of oxidative stress
Diabetologia
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
Diabetes
Adipokines and metabolic syndrome risk factors in women with previous gestational diabetes mellitus
Diabetes Metab Res Rev
Cited by (0)
- 1
These authors contributed equally to this study.